ArticleUltrasound in medicine & biology2018

Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.

Kyle P Hadinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.